SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3002MNTA ‘ReadMeFirst’ updated (mainly wrt M923/M230): siliconinvestor.comDewDiligence_on_SI-12/2/2016
3001MNTA ‘ReadMeFirst’ updated for 3Q16 results and other items: siliconinvestor.comDewDiligence_on_SI-11/4/2016
3000MNTA's CEO tells why at-risk launch of 40mg Copaxone likely: siliconinvestorDewDiligence_on_SI-8/28/2016
2999Yes, it does. Handicapping the 40mg-Copaxone market: siliconinvestor.com RegarDewDiligence_on_SI-8/24/2016
2998Patent office ruling today helps. still holding...mopgcw-8/24/2016
2997MNTA ‘ReadMeFirst’ updated for 2Q16 results and other info: siliconinvestor.comDewDiligence_on_SI-8/5/2016
2996MNTA ‘ReadMeFirst’ updated re 40mg-Glatopa & FoB programs: siliconinvestor.cDewDiligence_on_SI-5/8/2016
2995MNTA 2016-2017 News Flow (updated for 1Q16 CC): siliconinvestor.comDewDiligence_on_SI-5/8/2016
2994MNTA continues to have strong liquidity: siliconinvestor.comDewDiligence_on_SI-5/7/2016
2993The most important takeaway from today’s DB webcast is about FoB interchangeabilDewDiligence_on_SI-5/4/2016
2992Market has now discounted the last 10 years of MNTA's progress (based on theThe Ox-2/29/2016
2991Please use this link instead: siliconinvestor.comDewDiligence_on_SI-1/18/2016
2990MNTA ‘ReadMeFirst’ primer updated for MYL FoB partnership and other matters: siDewDiligence_on_SI-1/18/2016
2989MNTA's strong liquidity: siliconinvestor.comDewDiligence_on_SI-1/9/2016
2988MNTA 2016-2017 news flow (updated for MYL-MNTA FoB partnership): siliconinvestorDewDiligence_on_SI-1/9/2016
2987Why MYL-MNTA FoB partnership does not include Avastin: siliconinvestor.comDewDiligence_on_SI-1/9/2016
2986MNTA 2015-2017 news flow (updates for Humira FoB and Necupranaib): siliconinvesDewDiligence_on_SI-12/21/2015
2985Re: $100M Lovenox bond Please see siliconinvestor.com Regards, DewDewDiligence_on_SI-11/12/2015
2984Not sure what happens to the [$100M] bond. Thinking Amphastar collects due to DewDiligence_on_SI-11/11/2015
2983MNTA 2015-2017 news flow: siliconinvestor.comDewDiligence_on_SI-11/11/2015
2982"Mixed ruling" from CAFC on Lovenox litigation. CAFC mEnox ruling Astuck-11/10/2015
2981Glatopa’s volume share of 20mg Copaxone is 30%, which is “according to plan,” acDewDiligence_on_SI-10/27/2015
2980Not very many beautiful chrts out there, but MNTA has it. It can either hold $20Robohogs-8/28/2015
2979Appreciate the feedback. Regards, DewDewDiligence_on_SI-8/27/2015
2978I concur, which is why I am still holding. fwiw. mopgcw-8/27/2015
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News